Eiji Kumazawa
- Co-authors
- Akiko TohgoYusuke OchiAkio EjimaTakeshi JimboMasamichi SugimoriSatoru OhsukiIkuo MitsuiKouichi Uoto
- Topics
- Cancer therapeutics and mechanisms (12 papers)Synthesis and biological activity (5 papers)Cancer, Lipids, and Metabolism (4 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
In The Last Decade
Eiji Kumazawa
25 papers receiving 599 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 388
- Oncology 290
- Organic Chemistry 131
- Immunology 64
- Pharmacology 57
Countries citing papers authored by Eiji Kumazawa
This map shows the geographic impact of Eiji Kumazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Kumazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Kumazawa more than expected).
Fields of papers citing papers by Eiji Kumazawa
This network shows the impact of papers produced by Eiji Kumazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Kumazawa. The network helps show where Eiji Kumazawa may publish in the future.
Co-authorship network of co-authors of Eiji Kumazawa
This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Kumazawa. A scholar is included among the top collaborators of Eiji Kumazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Kumazawa. Eiji Kumazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 22 | |
| 3 | 26 | |
| 4 | 14 | |
| 5 | Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines. | 3 |
| 6 | 15 | |
| 7 | 18 | |
| 8 | 24 | |
| 9 | 22 | |
| 10 | 68 | |
| 11 | 6 | |
| 12 | 34 | |
| 13 | 21 | |
| 14 | 134 | |
| 15 | 9 | |
| 16 | DT-5461a, an antitumor synthetic lipid a analog, causes selective blood flow reduction in tumor tissue. | 10 |
| 17 | 12 | |
| 18 | 18 | |
| 19 | 15 | |
| 20 | 28 |
About Eiji Kumazawa
Eiji Kumazawa is a scholar working on Toxicology, Cancer Research and Oncology, having authored 25 papers that have together received 634 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Synthesis and biological activity (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Toxicology (44 citations), Oncology (290 citations) and Molecular Biology (388 citations). Eiji Kumazawa has collaborated with scholars based in Japan and Germany. Frequent co-authors include Akiko Tohgo, Yusuke Ochi, Akio Ejima, Takeshi Jimbo, Masamichi Sugimori, Satoru Ohsuki, Ikuo Mitsui, Kouichi Uoto, Hirofumi Terasawa and Masashi Aonuma. Their work appears in journals such as Blood, Pharmaceutical Research and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.